| Name | Title | Contact Details |
|---|
We do things differently here. Unlike old-school health insurance, ours is refreshingly simple, wallet-friendly and designed for your life. It’s health insurance you just might like.
Since our beginning in 1948, the Framingham Heart Study, under the direction of the National Heart, Lung and Blood Institute (NHLBI), formerly known as the National Heart Institute, has been committed to identifying the common factors or characteristics that contribute to cardiovascular disease (CVD). We have followed CVD development over a long period of time in three generations of participants.
Discovery Laboratories, Inc. is a specialty biotechnology company focused on advancing a new standard in respiratory critical care. Discovery Labs` technology platform includes its novel proprietary KL4 surfactant, a synthetic, peptide-containing surfactant that is structurally similar to pulmonary surfactant, and its proprietary drug delivery technologies being developed to enable efficient delivery of aerosolized KL4 surfactant and other inhaled therapies. Discovery Labs` strategy is initially focused on neonatology and improving the management of respiratory distress syndrome (RDS) in premature infants. Discovery Labs believes that its RDS product portfolio has the potential to become the new standard of care for RDS and, over time, enable the treatment of a significantly greater number of premature infants who could benefit from surfactant therapy that are currently not being treated. In many pulmonary diseases, including RDS, acute lung injury (ALI), and other respiratory conditions, surfactant is either deficient or may fail to function properly. Our precision-engineered, peptide-containing KL4 surfactant has been designed to mimic the essential function of human pulmonary surfactant and may have the potential to address conditions such as these. We are developing our proprietary delivery technologies to one day enable efficient, targeted upper-respiratory or alveolar delivery of our KL4 surfactant in aerosolized form to allow for a gentler, less invasive delivery approach. These same delivery systems may also potentially be used to deliver a variety of additional aerosolized medicines safely and in a simplified way compared with the current standard of care.
Herbalife Nutrition is a global nutrition company that has been helping people get healthier and happier since 1980. We operate in more than 90 countries worldwide and our products are sold exclusively by Herbalife Nutrition Independent Distributors. Our nutrition philosophy is simple: Combine balanced nutrition with a healthy, active life, and the one-on-one support of an Herbalife Independent Distributor. At Herbalife Nutrition, we source ingredients, such as aloe and tea, from select agricultural regions around the world. We have selected world-class micronutrient suppliers and are the largest purchaser of soy protein isolate in the United States. Our staff, state-of-the-art equipment and quality control systems help to ensure that every product meets our exacting quality standards which are among the highest in the industry. We support the Herbalife Family Foundation (HFF) and its Casa Herbalife programs to help bring balanced nutrition to children in need. Herbalife Nutrition also sponsors more than 190 world-class athletes, teams and events around the globe, including Cristiano Ronaldo, the LA Galaxy and champions in many other sports.
Obstetrix Medical Group is a Campbell, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.